Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

ImmunGene's Pipeline of Next Generation Cancer Therapeutics Featured in BioWorld Today

November 11, 2010 1:36 am | by Bio-Medicine.Org | News | Comments

THOUSAND OAKS, Calif., Nov. 11, 2010 /- ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that a profile of the company and its pipeline is featured in the...

TOPICS:

Pevion's Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study

November 11, 2010 1:36 am | by Bio-Medicine.Org | News | Comments

Pevion's Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase... -- ITTIGEN and BERN, Switzerland, November 11, 2010 /-...

TOPICS:

China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results

November 11, 2010 1:35 am | by Bio-Medicine.Org | News | Comments

HAIKOU CITY, China, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE Amex: CPHI ) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceuticals company in China, today announced financial results for the third quarter ended September...

TOPICS:
Advertisement

JDSU upbeat on comms and laser development

November 10, 2010 9:35 pm | by I-Micronews | News | Comments

Strong demand for optical components used in communications and new games consoles pushes quarterly revenue up to $411.3 million.

Althea Technologies Announces Appointment of Rick Hancock as President

November 10, 2010 9:33 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 11, 2010 /- Althea Technologies, Inc., a leading provider of contract development and manufacturing services for biopharmaceutical and parenteral products, announced today that Rick Hancock has been appointed President of the company.  Mr. Hancock brings twenty-seven...

TOPICS:

U of A researchers can predict heart transplant patient's health earlier

November 10, 2010 4:37 pm | by EurekAlert | News | Comments

(University of Alberta Faculty of Medicine & Dentistry) Michael Mengel, a pathology researcher with the Faculty of Medicine & Dentistry, has found a new way to analyze biopsies from heart transplant patients by looking at their genes. This allows him to make an early prediction...

TOPICS:

Stereotaxis Announces Public Offering of Common Stock

November 10, 2010 4:35 pm | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Nov. 10, 2010 /- Stereotaxis, Inc. (Nasdaq: STXS ) announced today that it intends, subject to market and other conditions, to offer its common stock in a registered public offering pursuant to its existing shelf registration statement under the Securities Act of 1933....

TOPICS:

Prevention 2010: Interview with Powel H. Brown, M.D., Ph.D.

November 10, 2010 4:35 pm | by AACR | News | Comments

In this podcast, Dr. Brown discusses the early detection of breast cancer, the effects of hormones and growth factors on gene expression and external risk factors for breast cancer.

TOPICS:
Advertisement

Prevention 2010: Interview with John D. Groopman, Ph.D.

November 10, 2010 4:35 pm | by AACR | News | Comments

Dr. Groopman talks about his landmark work in the field of hepatocellular carcinoma and the role of aflotoxins in the induction of this devastating liver cancer.

TOPICS:

Prevention 2010: Interview with Raymond N. DuBois, M.D., Ph.D.

November 10, 2010 4:35 pm | by AACR | News | Comments

Dr. DuBois discusses the challenges of cancer prevention as a public health issue, the scientific priorities for the next Stand Up To Cancer dream teams and the opportunities for the AACR in the areas of clinical and translational research.

TOPICS:

Prevention 2010: Interview with Eva Szabo, M.D.

November 10, 2010 4:35 pm | by AACR | News | Comments

Dr. Szabo talks about PPAR gamma as a target for aerodigestive cancer prevention, clinical trials and barriers that exist in clinical trial participation for prevention vs. treatment trials.

TOPICS:

Scripps, Kaiser Sign Deal to Collaborate

November 10, 2010 4:34 pm | by San Diego Business Journal | News | Comments

Scripps Health and Kaiser Permanente have signed a 10-year comprehensive agreement for Scripps to provide cardiac surgery, interventional cardiology and bariatric services to more than 500,000 Kaiser members across San Diego County.

TOPICS:

JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing

November 10, 2010 4:34 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Nov. 10, 2010 /PRNewswire-USNewswire/ -- Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth...

TOPICS:

Stereotaxis Receives Commitment to Increase and Extend Credit Facility

November 10, 2010 4:34 pm | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Nov. 10, 2010 /- Stereotaxis, Inc. (Nasdaq: STXS ) announced today that the Company has received a commitment letter from Silicon Valley Bank for an amended credit agreement that extends its revolving $30 million credit facility to March 31, 2012.  Consistent with the...

TOPICS:

Stereotaxis amends $30 million in credit(4)

November 10, 2010 3:46 pm | by The Associated Press | News | Comments

Stereotaxis Inc. said Wednesday that it received a commitment letter from Silicon Valley Bank for an amended credit agreement that extends its revolving $30 million credit facility to March 31, 2012.The revolving line of credit commitment includes a sublimit of $10 million for advances guaranteed...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading